Pharmaceutical Rebate Agreement for Natalizumab via Open-House Model
Notice title: Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Natalizumab (ATC-Code nach WHO: L04AG03)
Status
Active
Submission Deadline
424 days remaining
Contracting authority
Location
Erfurt, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-673520-2026
Source
Conclusion of a non-exclusive pharmaceutical rebate agreement according to § 130a para. 8 SGB V for the active ingredient Natalizumab (ATC code L04AG03) within an Open-House model.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 673520-2026HTML
- TED PDF — 673520-2026PDF
- TED XML — 673520-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
No
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024